A detailed history of Tang Capital Management LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 502,915 shares of ERAS stock, worth $1.19 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
502,915
Previous 550,000 8.56%
Holding current value
$1.19 Million
Previous $1.3 Million 5.7%
% of portfolio
0.12%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.17 - $3.28 $102,174 - $154,438
-47,085 Reduced 8.56%
502,915 $1.37 Million
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.63 $805,500 - $1.18 Million
450,000 Added 450.0%
550,000 $1.3 Million
Q1 2024

May 15, 2024

SELL
$1.67 - $2.55 $83,500 - $127,499
-50,000 Reduced 33.33%
100,000 $206,000
Q4 2023

Feb 14, 2024

BUY
$1.67 - $2.49 $250,500 - $373,500
150,000 New
150,000 $319,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $289M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.